| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project
|
Gilbert, Lucy
|
|
2012
|
13 |
3 |
p. 285-291
7 p.
|
artikel
|
| 2 |
Bevacizumab in HER2-negative non-metastatic breast cancer
|
Bennet, Neil
|
|
2012
|
13 |
3 |
p. e93-
1 p.
|
artikel
|
| 3 |
Beyond first-line NSCLC therapy: chemotherapy or erlotinib?
|
Paz-Ares, Luis
|
|
2012
|
13 |
3 |
p. 225-227
3 p.
|
artikel
|
| 4 |
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial
|
Cheung, Angela M
|
|
2012
|
13 |
3 |
p. 275-284
10 p.
|
artikel
|
| 5 |
Bone loss associated with prevention of breast cancer
|
Cauley, Jane A
|
|
2012
|
13 |
3 |
p. 221-222
2 p.
|
artikel
|
| 6 |
Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence
|
Morice, Philippe
|
|
2012
|
13 |
3 |
p. e103-e115
nvt p.
|
artikel
|
| 7 |
Breast cancer in Brazil: present status and future goals
|
Lee, Brittany L
|
|
2012
|
13 |
3 |
p. e95-e102
nvt p.
|
artikel
|
| 8 |
Closing in on accurate risk prediction and disease management for patients with operable GIST
|
Duensing, Anette
|
|
2012
|
13 |
3 |
p. 220-221
2 p.
|
artikel
|
| 9 |
Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial
|
Mann, Eleanor
|
|
2012
|
13 |
3 |
p. 309-318
10 p.
|
artikel
|
| 10 |
CT colonography screening
|
Gupta, Samir
|
|
2012
|
13 |
3 |
p. e90-
1 p.
|
artikel
|
| 11 |
Development and experimental medicine applications of PET in oncology: a historical perspective
|
Jones, Terry
|
|
2012
|
13 |
3 |
p. e116-e125
nvt p.
|
artikel
|
| 12 |
Does maintenance pemetrexed maintain quality of life?
|
Stinchcombe, Thomas E
|
|
2012
|
13 |
3 |
p. 224-225
2 p.
|
artikel
|
| 13 |
Early detection of ovarian cancer in symptomatic women
|
van Nagell Jr, JR
|
|
2012
|
13 |
3 |
p. 223-224
2 p.
|
artikel
|
| 14 |
Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study
|
Ciuleanu, Tudor
|
|
2012
|
13 |
3 |
p. 300-308
9 p.
|
artikel
|
| 15 |
End-of-life discussions are being left too late
|
Burki, Talha Khan
|
|
2012
|
13 |
3 |
p. e94-
1 p.
|
artikel
|
| 16 |
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|
Rosell, Rafael
|
|
2012
|
13 |
3 |
p. 239-246
8 p.
|
artikel
|
| 17 |
Ginger: the root of cancer therapy?
|
Krell, Jonathan
|
|
2012
|
13 |
3 |
p. 235-236
2 p.
|
artikel
|
| 18 |
Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study
|
Amant, Frédéric
|
|
2012
|
13 |
3 |
p. 256-264
9 p.
|
artikel
|
| 19 |
Maintenance chemotherapy in advanced non-small-cell lung cancer
|
Jassem, Jacek
|
|
2012
|
13 |
3 |
p. 217-218
2 p.
|
artikel
|
| 20 |
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
|
Paz-Ares, Luis
|
|
2012
|
13 |
3 |
p. 247-255
9 p.
|
artikel
|
| 21 |
Mind over menopausal symptoms in women with breast cancer
|
Prigerson, Holly G
|
|
2012
|
13 |
3 |
p. 227-229
3 p.
|
artikel
|
| 22 |
Multidisciplinary Head and Neck Cancer Symposium
|
Collingridge, David
|
|
2012
|
13 |
3 |
p. 232-
1 p.
|
artikel
|
| 23 |
Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest
|
van Noesel, Max M
|
|
2012
|
13 |
3 |
p. 229-230
2 p.
|
artikel
|
| 24 |
New narcotics policy could affect opioid prices in India
|
Sharma, DC
|
|
2012
|
13 |
3 |
p. e93-
1 p.
|
artikel
|
| 25 |
NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy
|
Rinaldi, Fiona
|
|
2012
|
13 |
3 |
p. 233-234
2 p.
|
artikel
|
| 26 |
Optimising therapy for EGFR-addicted NSCLC: just the start
|
Govindan, Ramaswamy
|
|
2012
|
13 |
3 |
p. 216-217
2 p.
|
artikel
|
| 27 |
Oral CDK4/6 inhibitor in clinical trials
|
Bennet, Neil
|
|
2012
|
13 |
3 |
p. e91-
1 p.
|
artikel
|
| 28 |
Phase i trialist
|
Scott, Jacob
|
|
2012
|
13 |
3 |
p. 236-
1 p.
|
artikel
|
| 29 |
Priorities for cancer prevention: lifestyle choices versus unavoidable exposures
|
Stewart, Bernard W
|
|
2012
|
13 |
3 |
p. e126-e133
nvt p.
|
artikel
|
| 30 |
Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study
|
Belani, Chandra P
|
|
2012
|
13 |
3 |
p. 292-299
8 p.
|
artikel
|
| 31 |
RAS mutations and the development of secondary tumours in patients given BRAF inhibitors
|
Sharma, Sharan Prakash
|
|
2012
|
13 |
3 |
p. e91-
1 p.
|
artikel
|
| 32 |
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts
|
Joensuu, Heikki
|
|
2012
|
13 |
3 |
p. 265-274
10 p.
|
artikel
|
| 33 |
Tobacco content in video games: 1994–2011
|
Barrientos-Gutierrez, Tonatiuh
|
|
2012
|
13 |
3 |
p. 237-238
2 p.
|
artikel
|
| 34 |
Tobacco control: time to protect children
|
The Lancet Oncology,
|
|
2012
|
13 |
3 |
p. 215-
1 p.
|
artikel
|
| 35 |
Treatment of maternal cancer and fetal development
|
Cardonick, Elyce
|
|
2012
|
13 |
3 |
p. 218-220
3 p.
|
artikel
|
| 36 |
US FDA advisory panel rejects early denosumab therapy
|
Furlow, Bryant
|
|
2012
|
13 |
3 |
p. e94-
1 p.
|
artikel
|
| 37 |
US FDA monitored whistleblowers' computers and emails
|
Furlow, Bryant
|
|
2012
|
13 |
3 |
p. 231-
1 p.
|
artikel
|
| 38 |
US firm corners exclusive license for RAD51C cancer gene
|
Furlow, Bryant
|
|
2012
|
13 |
3 |
p. e92-
1 p.
|
artikel
|
| 39 |
US rates of oral HPV infection
|
Burki, Talha Khan
|
|
2012
|
13 |
3 |
p. e92-
1 p.
|
artikel
|
| 40 |
Voices from the front: March
|
Mastrianni, David M
|
|
2012
|
13 |
3 |
p. 238-
1 p.
|
artikel
|
Tijdschrift beschrijving